- Home
- ABTS vs SONN Comparison
ABTS vs SONN Comparison
Compare ABTS & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABTS
- SONN
- Stock Information
- Founded
- ABTS 2010
- SONN N/A
- Country
- ABTS Hong Kong
- SONN United States
- Employees
- ABTS N/A
- SONN N/A
- Industry
- ABTS Computer Software: Programming Data Processing
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- ABTS Technology
- SONN Health Care
- Exchange
- ABTS Nasdaq
- SONN Nasdaq
- Market Cap
- ABTS 4.6M
- SONN 3.8M
- IPO Year
- ABTS N/A
- SONN N/A
- Fundamental
- Price
- ABTS $4.77
- SONN $1.25
- Analyst Decision
- ABTS
- SONN Strong Buy
- Analyst Count
- ABTS 0
- SONN 1
- Target Price
- ABTS N/A
- SONN $20.00
- AVG Volume (30 Days)
- ABTS 397.7K
- SONN 39.8K
- Earning Date
- ABTS 04-30-2025
- SONN 05-13-2025
- Dividend Yield
- ABTS N/A
- SONN N/A
- EPS Growth
- ABTS N/A
- SONN N/A
- EPS
- ABTS N/A
- SONN N/A
- Revenue
- ABTS $6,711,225.00
- SONN $1,000,000.00
- Revenue This Year
- ABTS N/A
- SONN $5,376.22
- Revenue Next Year
- ABTS N/A
- SONN N/A
- P/E Ratio
- ABTS N/A
- SONN N/A
- Revenue Growth
- ABTS 299.11
- SONN 978.39
- 52 Week Low
- ABTS $1.35
- SONN $1.08
- 52 Week High
- ABTS $14.10
- SONN $16.00
- Technical
- Relative Strength Index (RSI)
- ABTS 59.34
- SONN 51.70
- Support Level
- ABTS $3.75
- SONN $1.13
- Resistance Level
- ABTS $4.40
- SONN $1.21
- Average True Range (ATR)
- ABTS 0.53
- SONN 0.08
- MACD
- ABTS 0.01
- SONN 0.00
- Stochastic Oscillator
- ABTS 100.00
- SONN 56.67
About ABTS Abits Group Inc
Abits Group Inc is a digital data center operator with bitcoin self-mining operations.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.